Psychomotor Performance of Preterm Infants

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The first part involved 120 children in grades II and III of elementary schools. From this group, children were qualified for the second part of the study - 35 randomly selected children born on time (BoT) and 35 children born before 35 weeks of pregnancy (PB). EUROFIT tests, Vienna Tests and postural stability tests were carried out in both groups.

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT03671551` - Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
	Completed	`NCT05759351` - Appendectomy During Pregnancy and Child Development

NCT number	NCT05930522
Study type	Observational
Source	Gdansk University of Physical Education and Sport
Contact
Status	Completed
Phase
Start date	October 1, 2018
Completion date	March 30, 2020

Psychomotor Performance of Preterm Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms